Exciting news from Pretoria! The South Africa Health Products Regulatory Authority (SAHPRA) has inked a groundbreaking Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This monumental alliance, signed at the Egyptian Embassy, promises to foster vital collaboration and engagement on mutual reliance for pharmaceuticals, biological products, and medical devices.
This MOU marks the first of its kind between SAHPRA and a national regulatory authority in Africa, underlining our dedication to fostering collaboration and knowledge sharing with our African counterparts. The focus? Building capacity on the continent to ensure we stay rooted in regulatory processes.
This partnership holds potential for setting a unified vision and coordinating effective dialogue between African countries in the pharmaceutical industries sector.
The new partnership can remove barriers to trade, enhance people-to-people relations, and create a synergistic relationship where both regulators share knowledge and engage on areas of market authorization, pharmacovigilance, Good Manufacturing Practices (GMP) and clinical trials.
From Skepticism to Support: Healthcare Providers’ Acceptance of Digital Interventions in SUD Treatment in Kenya💡
Healthcare providers in Kenya show high acceptance of digital interventions for substance use disorder treatment. Learn more about how technology is shaping healthcare delivery.
#SyenzaNews #HealthcareInnovation #DigitalInterventions #SubstanceUseDisorder #KenyaHealthcare 🏥💻
📢 #SyenzaNews: The FDA is modernising regulations for AI medical devices with a firm-based approach. This shift focuses on the quality systems of manufacturing firms rather than individual product mechanics.
Discover how this new method can enhance safety and foster innovation in healthcare.
Read more here.
#LifeSciences #HealthcareInnovation #AIMedicalDevices #FDARegulations #HealthTech
Abu Dhabi is making remarkable progress in healthcare through strategic partnerships with leading institutions like CHOP and Penn Medicine. These collaborations aim to advance paediatric oncology, gene therapy, and translational research. 🌍💉
#SyenzaNews #HealthcareInnovation #PaediatricOncology #GeneTherapy #TranslationalResearch #AbuDhabiHealthcare
Read more about how these partnerships are set to transform healthcare in Abu Dhabi and beyond.
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
